Aster Capital Management’s Spruce Biosciences SPRB Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRB
ACM
Aster Capital Management's SPRB Position: Q3 2026 in Review
Aster Capital Management opened a new position in Spruce Biosciences (SPRB) in Q3 2026: 1 share worth $49. The stake represents ﹤0.01% of the portfolio and ranks #948 among its holdings.
70 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.
- Aster Capital Management held 1 share of Spruce Biosciences worth $49 as of Q3 2026.
- Spruce Biosciences was a new Aster Capital Management position in Q3 2026.
- Spruce Biosciences made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #948 holding.
- 70 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.